Pfizer settles Biohaven kickback claims case for $59.7m
Pharmaceutical Technology
JANUARY 27, 2025
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Pharmaceutical Technology
JANUARY 27, 2025
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Bio Pharma Dive
JANUARY 27, 2025
Taking control of O2 — ushering in the future of cell therapy research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 27, 2025
Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.
Bio Pharma Dive
JANUARY 27, 2025
Results showing Akero’s efruxifermin improved fibrosis by more than what Wall Street expected lifted the stock of both it and rival MASH developer 89bio.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JANUARY 27, 2025
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Bio Pharma Dive
JANUARY 27, 2025
Sage’s board of directors said Biogen’s offer “undervalues” the company, but will explore other strategic alternatives to “maximize” shareholder value.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
JANUARY 27, 2025
Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.
Pharmaceutical Technology
JANUARY 27, 2025
The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of Alzheimer's.
Bio Pharma Dive
JANUARY 27, 2025
Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and personalized patient programs.
Pharmaceutical Technology
JANUARY 27, 2025
The UK biotech sector raised 3.5bn in 2024, the highest annual total since 2021 when 4.5bn was raised.
pharmaphorum
JANUARY 27, 2025
A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.
Pharmaceutical Technology
JANUARY 27, 2025
Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North Carolina site.
pharmaphorum
JANUARY 27, 2025
Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.
Pharmaceutical Technology
JANUARY 27, 2025
Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JANUARY 27, 2025
China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.
Pharma Times
JANUARY 27, 2025
Study highlights VE303's potential in reducing recurrent CDI
pharmaphorum
JANUARY 27, 2025
Stay ahead of the game by keeping an eye on these six life sciences real estate trends to watch in 2025. From AI integration to collaborative incubator spaces, the industry is evolving rapidly.
Pharma Times
JANUARY 27, 2025
Comparison shows improved survival rates for pancreatic cancer treatment
pharmaphorum
JANUARY 27, 2025
UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.
Pharmaceutical Commerce
JANUARY 27, 2025
Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.
pharmaphorum
JANUARY 27, 2025
Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.
Pharmaceutical Commerce
JANUARY 27, 2025
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, shares the elements that manufacturers should consider when selecting a 3PL.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Tutor
JANUARY 27, 2025
Understanding the Impact of Guillain-Barr syndrome Pradip Mahajan Mon, 01/27/2025 - 15:41 Guillain-Barre syndrome (GBS) is an autoimmune disease. It's a rare neurological disorder that occurs when the body's immune system attacks its own peripheral nerves that carry signals from the brain and spinal cord to the rest of the body.
Pharmaceutical Commerce
JANUARY 27, 2025
The latest news for pharma industry insiders.
Drug Discovery World podcast
JANUARY 27, 2025
The latest episode of the DDW Highlightspodcast is now available to listen to below. DDWs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In the same week that Phesi revealed that breast cancer is the most studied disease for the fourth year in a row, we have seen a number of breakthroughs in the treatment of solid tumours, both in the early preclinical and later clinical stages of research.
Roots Analysis
JANUARY 27, 2025
Nuclear medicine is a medical specialty that involves the use of radionuclides or radioactive tracers in conjunction with highly specialized imaging instrumentation to detect the emissions in the body after oral, inhalation, or intravenous administration of radionuclides. A radioactive tracer is a drug that is composed of a short-lived medical isotope tightly attached to a carrier molecule.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 27, 2025
The approval is the first to come from the agency since the Trump administration paused all external communication from federal health agencies last week.
Roots Analysis
JANUARY 27, 2025
The American Society of Gene and Cell Therapy (ASGCT) defines cell therapy as a therapeutic modality that involves the administration of either normal or modified cells to patients for the treatment of various diseases. In this form of therapy, patients are injected with living and intact human cells that are deemed to be capable of providing therapeutic benefit.
Bio Pharma Dive
JANUARY 27, 2025
The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, one physician said.
Rethinking Clinical Trials
JANUARY 27, 2025
A new study snapshot and updated ethics and regulatory documentation are now available for the TAICHIKNEE trial. One year into the study, and after receiving approval to transition from the planning phase to the implementation phase, the research team reviewed and updated the minutes of their initial consultation with the Ethics and Regulatory Core.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content